scispace - formally typeset
PatentDOI

Production of high titer helper-free retroviruses by transient transfection

Reads0
Chats0
TLDR
In this article, a method for producing high-titer, helper-free infectious retroviruses is disclosed which employs a novel strategy that uses transient transfection of new retroviral producer cell lines, ecotropic line BOSC 23 and amphotropic line CAK 8.
Abstract
A method for producing high-titer, helper-free infectious retroviruses is disclosed which employs a novel strategy that uses transient transfection of new retroviral producer cell lines, ecotropic line BOSC 23 and amphotropic line CAK 8, both of which cell lines and their precursor cell lines are disclosed. Because of the advantages over stable packaging cell lines, the BOSC 23 and CAK 8 transient transfection systems greatly facilitate and extend the use of helper-free retroviral vectors. The cell lines and corresponding methods possess wide application in both the medical and biotechnical fields, including gene therapy. These potential applications are disclosed and illustrated.

read more

Citations
More filters
Journal ArticleDOI

Podocin localizes in the kidney to the slit diaphragm area.

TL;DR: In situ hybridization and electron microscopy demonstrate that podocin is facing the slit diaphragm with its two ends in the cytoplasm of the foot processes, in agreement with its predicted structure, suggesting thatpodocin could serve to anchor directly or indirectly components of the slitdiaphragms to the cytoskeleton.
Journal ArticleDOI

A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140.

TL;DR: This work reports the finding of novel 14-residue CXCR4 inhibitors, T134 and T140, on the basis of the T22 structure, which showed the highest inhibitory activity against HIV-1 entry and the strongest inhibitory effect on the binding of an anti-CX CR4 monoclonal antibody to CxCR4 among all the CXcr4 inhibitors that have been reported up to now.
Journal ArticleDOI

Transcription coactivator TRAP220 is required for PPARγ2-stimulated adipogenesis

TL;DR: Data indicate that TRAP220 acts, via the TRAP complex, as a PPARγ2-selective coactivator and, accordingly, that it is specific for one fibroblast differentiation pathway (adipogenesis) relative to another (myogenesis).
Journal ArticleDOI

PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors.

TL;DR: In this paper, the authors demonstrate that mutation of the PU.1 gene causes a severe reduction in myeloid (granulocyte/macrophage) progenitors.
Journal ArticleDOI

Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts

TL;DR: It is demonstrated that, in primary fibroblasts, inhibition of G1-specific Cdk activity is sufficient to induce phenotypic changes that normally occur at the end of their finite lifespan.
References
More filters
Journal ArticleDOI

Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5

TL;DR: Human embryonic kidney cells have been transformed by exposing cells to sheared fragments of adenovirus type 5 DNA, and the transformed cells exhibited many of the characteristics of transformation including the elaboration of a virus-specific tumour antigen.
Journal ArticleDOI

Vaccination with Irradiated Tumor Cells Engineered to Secrete Murine Granulocyte-Macrophage Colony-Stimulating Factor Stimulates Potent, Specific, and Long-Lasting Anti-Tumor Immunity

TL;DR: The results have important implications for the clinical use of genetically modified tumor cells as therapeutic cancer vaccines and the levels of anti-tumor immunity reported previously in cytokine gene transfer studies involving live, transduced cells could be achieved through the use of irradiated cells alone.
Journal ArticleDOI

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

TL;DR: It is demonstrated that P210bcr/abl expression can induce chronic myelogenous leukemia and retrovirus-mediated expression of the protein provides a murine model system for further analysis of the disease.
Journal ArticleDOI

The Basic Science of Gene Therapy

TL;DR: A large number of key technical issues need to be resolved before gene therapy can be safely and effectively applied in the clinic, and future technological developments will be critical for the successful practice of gene therapy.
Journal Article

Improved Retroviral Vectors for Gene Transfer and Expression

TL;DR: A set of murine retrovirus-based vectors that include unique cloning sites for insertion of cDNAs such that the cDNA can be driven by either the retroviral long terminal repeat, the immediate early promoter of human cytomegalovirus, or the simian virus 40 early promoter are described.
Related Papers (5)